Last reviewed · How we verify
NCT03413189: PREDICTABLE
The Effect of Exercise Dosage on Physical Function, Cognition and Disability Following Critical Illness
trial testing Review of medical records in Critical Illness in 40 participants. Status unknown.
30 December 2020
Quick facts
| Lead sponsor | Australian and New Zealand Intensive Care Research Centre |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 9 March 2018 |
| Primary completion | 30 December 2020 |
| Estimated completion | 31 December 2023 |
| Sites | 3 locations across Australia |
Drugs / interventions tested
- Review of medical records
- Assessment of physical and cognitive function
- Interview of patients, carers and/or family members
Conditions studied
- Critical Illness — all drugs for Critical Illness →
Sponsor
Australian and New Zealand Intensive Care Research Centre — full company profile →
Who can join
Adults 18 to 80, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Survival following a critical illness continues to improve with ongoing developments in medical management, however evidence shows that this patient group is at a high risk of suffering long term disability. The objectives are to determine if there is a link between the amount of exercise performed in intensive care on the presence of delirium, long term cognition and disability whilst ensuring that patient reported outcomes correlate with actual measured results, and to obtain information on recovery from patients and/or relatives to determine themes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03413189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Review of medical records
Trials testing the same drug.
- NCT03906747 — End-of-Life Management Protocol Offered Within Emergency Room: a Multicentre Study (EMPOWER) · unknown
Other recruiting trials for Critical Illness
Currently open trials in the same condition.
- NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
- NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
- NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
- NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
- NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
Other Australian and New Zealand Intensive Care Research Centre trials
Trials by the same sponsor.
- NCT07438262 — The AminoECMO Pilot Trial · Phase 2 · not yet recruiting
- NCT06576895 — Nutrition Practice in Critically Ill Adults · recruiting
- NCT05814094 — Red Blood Cell Transfusion in ECMO - A Feasibility Trial · NA · recruiting
- NCT05748860 — PRecision Ecmo in CardIogenic Shock Evaluation · not yet recruiting
- NCT05562505 — Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03413189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Australian and New Zealand Intensive Care Research Centre
- Last refreshed: 15 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03413189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing